| 发明名称 |
Nuclear Hormone Receptor Modulators |
| 摘要 |
The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
|
| 申请公布号 |
US2012238549(A1) |
申请公布日期 |
2012.09.20 |
| 申请号 |
US201213420957 |
申请日期 |
2012.03.15 |
| 申请人 |
CUSACK KEVIN P.;GORDON THOMAS D.;IHLE DAVID C.;HAYES MARTIN E.;BREINLINGER ERIC C.;ERICSSON ANNA M.;LI BIN;WANG LEI;MARTINEZ GLORIA Y.;BURCHAT ANDREW;HOBSON ADRIAN D.;MULLEN KELLY D.;FRIEDMAN MICHAEL;MORYTKO MICHAEL J.;ABBOTT LABORATORIES |
发明人 |
CUSACK KEVIN P.;GORDON THOMAS D.;IHLE DAVID C.;HAYES MARTIN E.;BREINLINGER ERIC C.;ERICSSON ANNA M.;LI BIN;WANG LEI;MARTINEZ GLORIA Y.;BURCHAT ANDREW;HOBSON ADRIAN D.;MULLEN KELLY D.;FRIEDMAN MICHAEL;MORYTKO MICHAEL J. |
| 分类号 |
A61K31/122;A61K31/44;A61K31/55;A61P1/00;A61P1/04;A61P1/16;A61P3/00;A61P3/04;A61P3/10;A61P5/00;A61P5/48;A61P7/10;A61P9/00;A61P9/12;A61P11/06;A61P13/12;A61P17/02;A61P17/06;A61P19/02;A61P19/04;A61P19/10;A61P25/00;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/02;A61P27/06;A61P29/00;A61P31/14;A61P31/18;A61P35/00;A61P35/02;A61P37/00;A61P37/02;A61P37/06;A61P37/08;C07C45/61;C07C45/62;C07C49/755;C07D213/74;C07D401/12;C07D453/04 |
主分类号 |
A61K31/122 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
